Verona Pharma (NASDAQ:VRNA) Price Target Raised to $90.00
Verona Pharma (NASDAQ:VRNA – Get Free Report) had its target price raised by research analysts at HC Wainwright from $85.00 to $90.00 in a report issued on Monday,Benzinga reports. The firm presently has a “buy” rating on the stock. HC Wainwright’s price target suggests a potential upside of 6.12% from the stock’s previous close. Several […]
Verona Pharma (NASDAQ:VRNA – Get Free Report) had its target price raised by research analysts at HC Wainwright from $85.00 to $90.00 in a report issued on Monday,Benzinga reports. The firm presently has a “buy” rating on the stock. HC Wainwright’s price target suggests a potential upside of 6.12% from the stock’s previous close. Several […]
